[
  {
    "ts": null,
    "headline": "Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors",
    "summary": "MELVILLE, N.Y., May 16, 2025--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein.",
    "url": "https://finnhub.io/api/news?id=712eacf8d25ab896dddf0697f3716009677173f2b4b0e0c0167490ef0c75be01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747426200,
      "headline": "Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors",
      "id": 134568135,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HSIC",
      "source": "Yahoo",
      "summary": "MELVILLE, N.Y., May 16, 2025--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein.",
      "url": "https://finnhub.io/api/news?id=712eacf8d25ab896dddf0697f3716009677173f2b4b0e0c0167490ef0c75be01"
    }
  },
  {
    "ts": null,
    "headline": "HSIC Q1 Earnings Call: Henry Schein Navigates Flat Revenue with Margin Resilience and Strategic Shifts",
    "summary": "Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $3.17 billion. Its non-GAAP profit of $1.15 per share was 3.6% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=3930d6c213dade0f6c98c3b2681e3f49ac6829f163caa95eebfd811a8f351b49",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747403169,
      "headline": "HSIC Q1 Earnings Call: Henry Schein Navigates Flat Revenue with Margin Resilience and Strategic Shifts",
      "id": 134568136,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HSIC",
      "source": "Yahoo",
      "summary": "Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $3.17 billion. Its non-GAAP profit of $1.15 per share was 3.6% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=3930d6c213dade0f6c98c3b2681e3f49ac6829f163caa95eebfd811a8f351b49"
    }
  }
]